Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Review

Published on 03 Mar 2025

The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases

in Pharmacology of Anti-Cancer Drugs

Weisong Zhang
Rui Wang
Rongqi Guo
Zhongquan Yi
Yihao Wang
Hao Wang
Yangyang Li
Xia Li
Jianxiang Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538601

1,680 views

Systematic Review

Published on 03 Mar 2025

Comparison of efficacy and safety of adjuvant therapies versus sorafenib in hepatocellular carcinoma: a systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Wenjun Quan
Hanifah Fazlin Zulkifli
Norhafizah Saari
Rafidah Hanim Shueb
Nazri Mustaffa

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1502931

1,671 views

Original Research

Published on 03 Mar 2025

Multi-omics analysis of the dynamic role of STAR+ cells in regulating platinum-based chemotherapy responses and tumor microenvironment in serous ovarian carcinoma

in Pharmacology of Anti-Cancer Drugs

Hongwei Lan
Weihua Yan
Xiao Huang
Jiali Cui
Helei Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545762

1,494 views

Original Research

Published on 28 Feb 2025

Dehydrodiisoeugenol targets the PLK1-p53 axis to inhibit breast cancer cell cycle

in Pharmacology of Anti-Cancer Drugs

Lin Li
Yifan Zheng
Yongxia Yang
Senlin Shi
Shangjie Liu
Keying Huang
Luonan Qiu
Rongxin Zhang
Wenbin Huang
Yin Leng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545498

1,345 views

Mini Review

Published on 28 Feb 2025

Research progress on ferroptosis in Myelodysplastic syndromes

in Pharmacology of Anti-Cancer Drugs

Yifan Yang
Jiongping Han
Yuxin Wei
Jiacheng Jin
Weiyin Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561072

1,354 views

Original Research

Published on 28 Feb 2025

Repurposing hydrochlorothiazide (HCTZ) for colorectal cancer: a retrospective and single center study

in Pharmacology of Anti-Cancer Drugs

Dominic Chi-Chung Foo
Jiaxi Li
Zheng Huang
Siming Sui
Ryan Wai-Yan Sin
Abraham Tak Ka Man
Wai-Lun Law
Lui Ng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1449062

730 views

Original Research

Published on 26 Feb 2025

Small molecule inhibition of ubiquitin C-terminal hydrolase L1 alters cell metabolism proteins and exerts anti- or pro-tumorigenic effects contingent upon chemosensitivity status in high grade serous ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Corinne Jansen
Julia McAdams
Chloe Kim
Payton De La Cruz
Angelica Salaverria
Nicholas A. DaSilva
Kathryn Grive
Nicole E. James

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547164

1,011 views

Review

Published on 26 Feb 2025

Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives

in Pharmacology of Anti-Cancer Drugs

Xiaoya Li
Fang Yang
Meijing Wang
Xiaopeng Huang
Xin Zeng
Lu Zhou
Sixue Peng
Jingyi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1478331

3,138 views

Original Research

Published on 26 Feb 2025

Signal mining and analysis of ripretinib adverse events: a real-world pharmacovigilance analysis based on the FAERS database

in Pharmacology of Anti-Cancer Drugs

Ye Hu
Linlin Zhang
Qineng Gong
Lei Huang
Cunlin Yin
Yang Miao
Hui Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1481114

2,354 views

Review

Published on 26 Feb 2025

Mitochondria-associated non-coding RNAs and their impact on drug resistance

in Pharmacology of Anti-Cancer Drugs

Xingna An
Lina Sun
Huan Zheng
Yinghui Xiao
Weixia Sun
Dehai Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1472804

1,287 views

Systematic Review

Accepted on 25 Feb 2025

Efficacy and safety of immunotherapy or antiangiogenic agents-based treatment strategies versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Chengjun Wang
chuang yang
wen zhao
Rongyu Zhang
Tiantian Xuan
Jisheng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1539246

210 views

Original Research

Published on 25 Feb 2025

Fenvalerate exposure induces AKT/AMPK-dependent alterations in glucose metabolism in hepatoma cells

in Pharmacology of Anti-Cancer Drugs

Lu Sun
Zheng-Guo Cui
Qianwen Feng
Jibran Sualeh Muhammad
Yu-Jie Jin
Songji Zhao
Lingqi Zhou
Cheng-AI Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540567

1,273 views

Review

Published on 24 Feb 2025

Asiatic acid in anticancer effects: emerging roles and mechanisms

in Pharmacology of Anti-Cancer Drugs

Rong Chen
Wan Zhang
Meizhi Zhang
Weidong Liu
Weike Feng
Yanan Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545654

1,106 views

Original Research

Published on 24 Feb 2025

Cepharanthine hydrochloride: a novel ferroptosis-inducing agent for prostate cancer treatment

in Pharmacology of Anti-Cancer Drugs

Jing-Song Guan
Jing Jia
Ze-Xiu Huang
Yu-Qing Zhou
Jing-Jie Zheng
Qi-Man Lin
Yi-Fei Wang
Jiang-Lin Fan
Yao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536375

1,866 views
1 citation

Original Research

Published on 24 Feb 2025

Gold complex QB1561 suppresses drug-resistant cancer cells by inhibiting TrxR and mitochondrial respiratory function

in Pharmacology of Anti-Cancer Drugs

Hai-Ling Gao
Wenwen Ding
Zhi-Xin Shen
Qingbin Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1560880

1,543 views

Mini Review

Published on 21 Feb 2025

Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives

in Pharmacology of Anti-Cancer Drugs

Xianglong Shi
Kai Tang
Quanbin Zhang
Qingkun Han
Lin Quan
Yijing Li
Jianqiao Cui
Nuan Feng
Jianbao Gong
Baoxin Shang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1556245

3,078 views
1 citation